International Society of Paediatric Oncology – SIOP shared a post on LinkedIn:
“In Honor of Survivor Week: Join Our Next Global Webinar
Treatment-related hearing loss remains one of the most impactful late effects in paediatric oncology. To address this critical challenge, the SIOP Survivorship Special Interest Group, supported by Childhood Cancer International SurNet, invites you to a collaborative, multi-stakeholder educational initiative.
Date: June 10, 2026 Time: 3:00 PM CET | 9:00 AM EST Format: Live
Register today to secure your spot: here.
Interactive Webinar (Two Parts)
Ototoxicity: Prevention Trials and Clinical Perspectives
This global programme brings together leading clinicians, researchers, survivors, and advocates to discuss evolving clinical evidence, preventive strategies, and firsthand survivorship perspectives in ototoxicity care.
Part I: Scientific Panel – Current Research & Clinical Insights Focused discussions on Sodium Thiosulfate (STS) preventive clinical trials and evolving clinical practices.
Dr. David Freyer (Children’s Hospital Los Angeles, USA) on preventing cisplatin-induced ototoxicity.
Dr. Rod Rassekh (University of British Columbia & BC Children’s Hospital, Canada) on the complex genetics of chemotherapy-induced ototoxicity.
Moderated by Nurdan Tacyildiz and Maria Olsson.
Part II: Round Table – Lived-Experience & Multi-Stakeholder Dialogue A dedicated session highlighting the true impact of treatment-related hearing loss and long-term survivorship care needs.
Prof. Kristy Knight (Audiologist Perspective, OHSU, USA)
Dr. Sonay Ozdemir (Paediatric Oncologist LMIC Perspective, Ankara, Türkiye)
Sidney Chahonyo (Survivor Perspective, Hope for Cancer Kids)
Usha Sudheer (Parent Perspective, India)
Moderated by Sidney Chahanyo and Patrick Yip.
Together, let’s advance hearing preservation and improve the quality of life for childhood cancer survivors worldwide.
Target Audience: Healthcare professionals, researchers, survivors, patient advocates, and global paediatric oncology stakeholders.
Register today to secure your spot: here.
This is an independent educational activity supported by an unrestricted educational grant from Norgine. The scientific programme and content are developed independently by the scientific committee without influence from Norgine.”
Other articles about Childhood Cancer on OncoDaily.